MNBTD
AMPH icon

Moody National Bank Trust Division’s Amphastar Pharmaceuticals AMPH Stock Holding History

Moody National Bank Trust Division’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-239
Closed -$5K – 391
2019
Q1 		$5K Hold
239
– – ﹤0.01% 855
2018
Q4 		$5K Buy
+239
New +$4.71K ﹤0.01% 743

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Moody National Bank Trust Division's AMPH Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2019, closing a stake of 239 shares — an estimated $5K sold.

Moody National Bank Trust Division first reported a position in AMPH in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 133 funds tracked by Wall St. Rank hold AMPH as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Amphastar Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 239 Amphastar Pharmaceuticals shares in Q2 2019, an estimated $5K.
  • Moody National Bank Trust Division first reported a position in Amphastar Pharmaceuticals in Q4 2018 and held it in 2 quarters.
  • Moody National Bank Trust Division's Amphastar Pharmaceuticals position peaked at $5K in Q1 2019.
  • 133 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.